Drugstores struggle to keep Covid at-home tests in stock as omicron rages across U.S.
[ad_1]
A free Covid-19 rapid test kit at home is available from health professionals at a Philadelphia vaccination clinic on Monday Dec. 20, 2021.
Bloomberg | Bloomberg | Getty Images
George Panagiotopoulos, a New York City neighborhood pharmacist Broadway Chemists has struggled to stock Covid-19 at-home tests at the pharmacy as Covid19 cases rise to new highs throughout the country and the U.S.
The Saturday before Christmas shipment of 200 testing kits sold out in a matter of minutes, he stated.
Panagiotopoulos owns the pharmacy and had 110 names on his waiting list to stock at-home test kits the Tuesday before Christmas. According to Panagiotopoulos, the 150-kit shipment arrived late on Thursday and was sold out in less than 48 hours. Broadway Chemists received a second shipment of 150 testing kits last Thursday. But most were gone within one day.
The pharmacy only had 20-30 tests in stock as of Friday afternoon. Panagiotopoulos anticipates that demand will remain high, as schools and parents rush to have their children tested after the holiday break.
His Covid hotspots all across the country are witness to this as infection have occurred. reached all-time highsIn the U.S. driven by the contagious variant of omicron.
The ‘Tsunami effect’
Bidding war
John Koval said Abbott received an FDA emergency approval in March for the BinaxNOW test at home.
“We’re shipping them out as soon as we can,” he stated. He said, “This involves running U.S. factories 24/7, investing in automation and hiring more workers.”
Shaz Amin is the founder of WellBefore Online, which sells online at-home testing. He said that the increase in demand has enabled distributors to raise prices because buyers such as his have been in a bid war for limited supplies.
Amin said, “Whatever test kits we paid a week earlier, we pay 25% today.” “Someone has gotten in front of us and said, ‘I’ll pay 25c more for you to get what WellBefore’s allocation is.
Amin stated that the Covid kits have been sold out before arriving.
Prepayment
Ryen Neuman is vice president of logistics for Sunline Supply and Arnold’s Office Furniture. He said that clients turned to Sunline Supply for PPE and testing kits during the pandemic.
However, Covid test kit purchasers “must pay 100%” of the product before even looking at, touching, or smelling the product. Test kits are so in high demand that they have to “pay it all,” he stated, adding that the market will remain “tight” for at most six months.
He stated, “It just seems that the production isn’t capable of ramping up to meet the American people’s needs right now.”
Many wholesale buyers stated that they want to carry lesser-known brands approved by the Food and Drug Administration and perform similarly to Covid test names. Abbott’sBinaxNOW Quidel’s QuickVue. Neuman stated that distributors who sell the most well-known tests may be charging too high, which makes the less popular brands seem more appealing.
Lack of raw material
Matt Regan, President and CEO at Code 1 Supply Medical Goods Distributor, stated Thursday that parts for the test kits had dried up during the last seven to 10 days. Regan stated that business partners told him there is a shortage in raw materials needed for test kits. He also heard from them that federal agencies are being prioritized by distributors over all other buyers.
CNBC spoke to three other Covid companies, Sunline Supply, iPromo and non-profit Project N95. They said that they had been similarly informed by the Biden administration that the new plan of 500 million at home tests was delaying their own shipments. However, the White House said that it shouldn’t hinder existing deals between private parties.
A White House official stated in a statement that “Because this capacity is available, we can make the purchase without disrupting supply to existing manufacturer’s commitments to states and organizations”, according to CNBC.
However, it is not easy to quickly ramp up manufacturing of test components, according to Steven Tang, chief executive officer at OraSure Technologies. According to him, there’s a shortage in several components for test manufacturing. It is also difficult to staff up with more workers to produce more tests when the demand fluctuates.
Tang explained that in May and June when people believed vaccines would solve everything, they began decreasing the supply and decreasing the labor and shifts. According to Tang, testing was in high demand again as the season progressed. He said that businesses, especially those in scaling, flourish when there’s consistency and predictability. “We are not currently in a stable and predictable environment,” he stated.
Production ramping
As you can see, manufacturers of test kits are expanding production. New companies, however, are still waiting to be approved by the FDA before they sell their tests to the general public. Some wholesalers believe that Covid test kits will be available more quickly in the future.
Amin of WellBefore said that the country will be “better” in testing in the second quarter. If the FDA approves additional tests within the next weeks, it may even be sooner.
Anne Miller, Executive Director of Project N95 thinks that testing will start to ease around the middle this month.
Abbott is increasing its supply as one of America’s biggest test manufacturers. According to Koval, 70 million BinaxNOW fast tests will be conducted in January. That’s up from 50,000,000 in December.
This report was contributed by Sevanny Campos, CNBC.
WATCH: Biden administration to distribute 500 million free at-home Covid tests
[ad_2]